US Patent Number

10,604,756

Publication Date

3-31-2020

Abstract

The present invention relates to methods for protecting against damage caused by radiation and/or chemotherapy, and methods for treating bone marrow damage by reducing/ inhibiting Latexin expression and/or Latexin activity. The methods comprise administering to a subject in need thereof a pharmaceutical composition comprising an antagonist that reduces expression and/or activity of latexin, wherein latexin is a latexin polynucleotide variant and/or a latexin polypeptide variant that binds to the antagonist.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

14/879,577

Filing Date

10-9-2015

Share

COinS